Style | Citing Format |
---|---|
MLA | Kheradjoo H, et al.. "Mesenchymal Stem/Stromal (Mscs)-Derived Exosome Inhibits Retinoblastoma Y-79 Cell Line Proliferation and Induces Their Apoptosis." Nanomedicine Research Journal, vol. 7, no. 3, 2022, pp. 264-269. |
APA | Kheradjoo H, Nouralishahi A, Firozabdi MSH, Mohammadzadehsaliani S (2022). Mesenchymal Stem/Stromal (Mscs)-Derived Exosome Inhibits Retinoblastoma Y-79 Cell Line Proliferation and Induces Their Apoptosis. Nanomedicine Research Journal, 7(3), 264-269. |
Chicago | Kheradjoo H, Nouralishahi A, Firozabdi MSH, Mohammadzadehsaliani S. "Mesenchymal Stem/Stromal (Mscs)-Derived Exosome Inhibits Retinoblastoma Y-79 Cell Line Proliferation and Induces Their Apoptosis." Nanomedicine Research Journal 7, no. 3 (2022): 264-269. |
Harvard | Kheradjoo H et al. (2022) 'Mesenchymal Stem/Stromal (Mscs)-Derived Exosome Inhibits Retinoblastoma Y-79 Cell Line Proliferation and Induces Their Apoptosis', Nanomedicine Research Journal, 7(3), pp. 264-269. |
Vancouver | Kheradjoo H, Nouralishahi A, Firozabdi MSH, Mohammadzadehsaliani S. Mesenchymal Stem/Stromal (Mscs)-Derived Exosome Inhibits Retinoblastoma Y-79 Cell Line Proliferation and Induces Their Apoptosis. Nanomedicine Research Journal. 2022;7(3):264-269. |
BibTex | @article{ author = {Kheradjoo H and Nouralishahi A and Firozabdi MSH and Mohammadzadehsaliani S}, title = {Mesenchymal Stem/Stromal (Mscs)-Derived Exosome Inhibits Retinoblastoma Y-79 Cell Line Proliferation and Induces Their Apoptosis}, journal = {Nanomedicine Research Journal}, volume = {7}, number = {3}, pages = {264-269}, year = {2022} } |
RIS | TY - JOUR AU - Kheradjoo H AU - Nouralishahi A AU - Firozabdi MSH AU - Mohammadzadehsaliani S TI - Mesenchymal Stem/Stromal (Mscs)-Derived Exosome Inhibits Retinoblastoma Y-79 Cell Line Proliferation and Induces Their Apoptosis JO - Nanomedicine Research Journal VL - 7 IS - 3 SP - 264 EP - 269 PY - 2022 ER - |